Dow Up 0.17% Nasdaq Up 0.29%

Stemline Therapeutics, Inc. (STML)

-NCM
11.56 0.06(0.52%) Aug 26, 4:00PM EDT
Prev Close:11.50
Open:11.50
Bid:10.98 x 200
Ask:21.25 x 300
1y Target Est:59.00
Beta:-4.709
Earnings Date:Oct 20 - Oct 24 (Est.)
Day's Range:11.42 - 11.81
52wk Range:10.51 - 47.25
Volume:163,949
Avg Vol (3m):137,383
Market Cap:149.66M
P/E (ttm):N/A
EPS (ttm):-2.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for STML

Comparison

Symbol% ChgMkt Cap
STMLUp 0.52%149.66M
OMED592.52M
VSTM235.42M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):697.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.39
Quarterly EPS Est (Sep-14) :-0.58
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary therapeutics for cancer stem cells and bulk tumors in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback